About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,039 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,039 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3121-3140 of 8,039 trials

Not yet recruitingEvaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and DabrafenibThe purpose of this study is to observe the safety and efficacy of Aspirin combined with Trametinib and Dalafenib in the treatment of advanced BRAF V600E mutated non-small cell…NCT05988697 UnknownCamrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLCExplorative study, which evaluates the effect of Camrelizumab combined with albumin-bound paclitaxel and platinum in neoadjuvant treatment of resectable non-small-cell lung…NCT04338620·Xi'an, Shaanxi CompletedA Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be ControlledThe purpose of this study is to learn about lorlatinib for the possible treatment of lung cancer which could not be controlled.NCT06282991·Kaohsiung City and 5 others RecruitingAK129 Combination Therapy for Advanced Solid TumorsThis is an open, multicenter phase Ib/II clinical study.NCT06943820·Shenyang, Liaoning

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedA Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung CancerThis 2 arm study will compare the efficacy and safety of sequential treatment with Tarceva or placebo, plus platinum-based therapy, as first line treatment in patients with…NCT00883779·Beijing and 25 others

RecruitingA Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsThe purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.NCT06835569·Orlando, Florida and 13 others

RecruitingA Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid TumorsThis is a multicenter, open-label, phase Ib/II study of YL202 in combination with other anti-tumor therapies to Evaluate the Safety, Tolerability, and Efficacy in Patients with…NCT07169994·Hefei, Anhui and 19 others

CompletedVaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00019929·Bethesda, Maryland and 1 other

CompletedThe Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC TrialThe goal of this study is to explore if, for locally advanced non-small cell lung cancer patients whose tumors have high levels of PD-L1 (a marker associated with benefits from…NCT03523702·The Bronx, New York

TerminatedHigh Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung CancerThis trial studies how well high dose vitamin A compound works in treating participants with non-small cell lung cancer that can be removed by surgery.NCT03870529·Winston-Salem, North Carolina

CompletedPhase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC PatientsThe main objective of this study is to evaluate the safety and tolerability of HM61713.NCT01588145·Seoul

CompletedErlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckThis phase I/II trial is studying the side effects of erlotinib and to see how well it works in treating patients with metastatic or unresectable non-small cell lung cancer…NCT00063895·Chicago, Illinois

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00014456·Lebanon, New Hampshire

Active not recruitingTreatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic AlterationsPlanned study population consists of approximately 1500 adult patients with a/m NSCLC in Russia, in about 20 oncological centers (in each center it is expected to recruit about 75…NCT06245837·Arkhangelsk and 15 others

WithdrawnItacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsThe purpose of this study is to determine if Itacitinib in combination with erlotinib is safe and effective in the treatment of nonsquamous non-small cell lung cancer (NSCLC) that…NCT02355431·Ogden, Utah

CompletedAssessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung CancersComputed tomography (CT) images, used for radiotherapy planning, are often caught out in lung target volumes delineation because of their inability to differentiate between…NCT01421953·Bordeaux

Active not recruitingA Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsThis study will assess the safety and efficacy of Osimertinib with Amivantamab as First-line Treatment in Participants with Epidermal Growth Factor Receptor Mutation-Positive…NCT05801029·Hong Kong and 27 others

CompletedAI Models for Predicting Occult Pleural Dissemination in NSCLCOccult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and…NCT07065422·Chongqing

TerminatedAscorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)This is a descriptive, proof of concept, open-label, randomized, 3-arm, window of opportunity trial to evaluate the immunomodulatory role of pharmacological ascorbate with…NCT06083454·Iowa City, Iowa

CompletedStudy of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung CancerThis is a Phase 1b/2 study. In Phase 1b, subjects will know the treatment they are receiving.NCT01211483·Glendale, Arizona and 51 others

PreviousPage 157 of 402Next